If a patient was taking thyrox 50 for hypothyroidism, then suddenly once her tsh went up to 17. And then she started taking thyrox 75 and after 6 weeks the tsh dropped to 0.9 What is the normal protocol now? Should she switch from 75 to 50 now?
Checking Date & Time
Reading File
Finding Sources
Searching PubMed
levothyroxine dose adjustment hypothyroidism TSH normalization
Finding Sources
Finding Sources
Reading File
Reading File
I now have enough information from authoritative sources to give a comprehensive answer.
Should she switch back from Thyrox 75 to Thyrox 50?
Short answer: No — not necessarily, and certainly not without clinical reassessment. Here's the reasoning:
What happened here
| Phase | Dose | TSH |
|---|---|---|
| Previously stable | Thyrox 50 mcg | Normal |
| TSH rose | Thyrox 50 mcg | 17 mIU/L (overt hypothyroid) |
| After 6 weeks | Thyrox 75 mcg | 0.9 mIU/L (normal) |
A TSH of 0.9 mIU/L is within the normal reference range (typically 0.4–4.0 mIU/L). This is a successful response to the dose increase.
Why she probably needs to stay on Thyrox 75
-
Thyrox 50 clearly became insufficient. Her TSH rose to 17 on 50 mcg — meaning that dose was no longer meeting her thyroid requirements. This can happen due to:
- Progression of autoimmune thyroiditis (most common cause)
- Weight gain
- Drug interactions (iron, calcium, PPIs, cholestyramine)
- Malabsorption
- Compliance issues
- Pregnancy
-
Going back to 50 would likely cause TSH to rise again, since that dose had already failed.
-
Steady state takes 6 weeks. The ATA confirms TSH should be measured no earlier than 4–6 weeks after a dose change, which is exactly what was done here. The result (TSH 0.9) is a valid, stable reading on Thyrox 75.
"Steady-state concentrations of the drug are reached by approximately 6 weeks after starting treatment or changing the dose." — Tietz Textbook of Laboratory Medicine, 7th Ed.
The standard protocol now (per ATA guidelines)
- Continue Thyrox 75 mcg — the current dose is achieving the target TSH.
- Recheck TSH in 4–6 months to confirm continued stability at this dose.
- Then annually, as long as she remains euthyroid and asymptomatic.
- Investigate why the dose requirement increased (rule out progression of thyroiditis, drug interactions, absorption issues).
"TSH monitoring is repeated after 4–6 months and then yearly when the patient has reached the optimal dose." — ATA Guidelines (cited in Tietz Textbook)
When would reverting to 50 make sense?
Only if there's a clear reversible cause that has now been corrected — for example:
- She was previously on a drug that decreased absorption (now stopped)
- Weight loss bringing her back to original body weight
- She was pregnant (now postpartum)
In those cases, a careful step-down with TSH recheck in 6 weeks would be appropriate.
Bottom line
Her current TSH of 0.9 on Thyrox 75 is a clinical success. The correct next step is to continue Thyrox 75 and recheck TSH in 4–6 months. Switching back to 50 without a specific reversible reason risks returning her to overt hypothyroidism (TSH 17 again), with all its associated symptoms and risks.
What happens if tsh started continuously dropping and went below normal range with this dose of medicine?!
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Good — I have what I need. Let me also pull the Tietz section that mentioned toxicity from the previous context.
If TSH Keeps Dropping Below Normal on Thyrox 75
This is called iatrogenic (exogenous) subclinical or overt hyperthyroidism — the dose is now too high for the patient's current needs.
What "TSH below normal" means in this context
| TSH Level | Interpretation | Urgency |
|---|---|---|
| 0.1–0.4 mIU/L | Mildly suppressed | Monitor closely |
| <0.1 mIU/L | Subclinical hyperthyroidism | Act — reduce dose |
| Undetectable + raised T3/T4 | Overt iatrogenic hyperthyroidism | Act urgently |
What can cause TSH to keep dropping on a fixed dose?
The patient's own thyroid may be recovering or fluctuating — this is common in autoimmune thyroiditis (Hashimoto's), where thyroid function can swing over time. Other causes:
- Unintentional weight loss
- Dietary changes affecting absorption
- Stopping a drug that previously interfered with absorption (iron, calcium, PPIs)
Risks of a persistently low TSH
Even if T3/T4 are still normal (subclinical hyperthyroidism), chronic TSH suppression carries real risks:
- Atrial fibrillation — significantly increased risk, especially in older patients
- Bone loss (osteoporosis/fractures) — accelerated especially in postmenopausal women
- Heart failure and coronary artery disease
- Dementia — emerging evidence of association
- Palpitations, anxiety, tremor, heat intolerance, weight loss — symptoms of overt hyperthyroidism if T3/T4 also rise
"Subclinical hyperthyroidism (low TSH <0.5 mU/L) may have only mild symptoms but carries increased risk of atrial fibrillation, heart failure, coronary artery disease, bone loss, fractures, and dementia." — Miller's Anesthesia, 10th Ed.
"If dosage is too great, toxicity mirrors symptoms of hyperthyroidism — nervousness, palpitations, tachycardia, heat intolerance, unexplained weight loss." — Lippincott Illustrated Reviews: Pharmacology
The correct clinical protocol
- Step down the dose — go back to Thyrox 50 mcg (or try an intermediate if available, e.g., alternating 50/75 on different days)
- Recheck TSH in 6 weeks after the dose reduction (this is the minimum time needed for a valid TSH reading)
- Target TSH 0.5–2.5 mIU/L for most adults (tighter range of 0.5–1.5 mIU/L if younger; higher acceptable in the elderly)
- Investigate the reason for the shifting dose requirement — autoimmune thyroiditis with partial recovery? Weight change? Drug interaction resolved?
Key principle
The goal is the lowest dose that keeps TSH within the normal range. Since TSH 0.9 is currently normal, you watch and wait — but if at the 4–6 month recheck TSH has dropped below 0.4, that's the trigger to reduce back toward 50 mcg (or alternate dosing).
This patient may ultimately need dose fine-tuning between 50 and 75 mcg — a common real-world scenario with Hashimoto's hypothyroidism where thyroid reserve fluctuates.
So how about we do a test again after 6weeks to confirm if tsh has dropped below normal?
Yes, that's a perfectly reasonable and clinically sound plan.
Recheck TSH at 6 weeks on the current Thyrox 75 dose — this is exactly aligned with the standard protocol. Here's why it makes sense:
Why 6 weeks is the right interval
- Levothyroxine has a ~7-day half-life, and steady state takes ~5–6 half-lives to fully establish
- TSH response lags behind actual thyroid hormone levels by several weeks
- Checking before 6 weeks gives a falsely moving/unreliable TSH reading
- 6 weeks gives you a true, stable reflection of what this dose is doing
What to expect at the recheck
| Result | Interpretation | Action |
|---|---|---|
| TSH 0.4–4.0 (still normal) | Dose is appropriate | Continue 75, recheck in 4–6 months |
| TSH <0.4 (suppressed) | 75 mcg is now too much | Step down — reduce dose or alternate 50/75 |
| TSH rising back up | 75 is becoming insufficient | Investigate cause, may need to stay on 75 |
One practical tip
When she gets the blood test, she should:
- Take it in the morning before her thyrox dose that day
- Fast or avoid coffee beforehand
- Test at roughly the same time of day each visit for consistency
This avoids falsely high T4 readings that can occur if blood is drawn 2–3 hours after taking the tablet.
So the plan is solid: continue Thyrox 75, recheck TSH at 6 weeks, then decide. If it's drifting low at that point, step back down toward 50.
This is a shared conversation. Sign in to Orris to start your own chat.